What You Should Know
Digital health provider Hinge Health, Inc. announced a definitive agreement to acquire virtual-first digestive care company Cylinder Health, Inc. for $105M in cash.The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions.Cylinder Health brings an established commercial footprint covering nearly 100 enterprise clients across two million lives, partnerships with two of the three largest PBMs, and commercial relationships
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
CMS’ Proposed Changes to Remote Monitoring Could Reshape Digital Healthcare Delivery
Over the past decade, remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) have transformed from emerging technologies into integral components of chronic disease management. Fueled by advances in connected medical devices, wearable sensors, digital therapeutics, artificial intelligence (AI), and virtual care platforms, remote monitoring has expanded providers' ability to manage patients beyond the traditional clinical setting while supporting earlier intervention and improved
Read More
Wellinks Raises $10M to Scale Predictive Cardiopulmonary Remote Patient Monitoring
What You Should Know
New Haven-based cardiopulmonary digital health provider Wellinks closed a $10M first tranche of its Series B funding round.The financing was led by strategic partner UMass Memorial Health alongside participation from existing inside investors.Wellinks' FDA-cleared Spire Remote Patient Monitoring (RPM) System and proprietary Health Tags deliver passive, continuous physiological tracking to predict clinical deterioration up to one week before symptom onset.Clinical evidence
Read More
4DMedical Invests $3.4M in RevealDx to Build a Connected Cardiopulmonary Platform
What You Should Know
Seattle-based RevealDx has secured a $3.4M strategic investment and a global distribution agreement with Melbourne-listed 4DMedical.The agreement appoints 4DMedical as the distributor for RevealDx's flagship software, RevealAI-Lung, across the United States, Europe, Australia, and New Zealand.RevealAI-Lung is an AI CADx software that generates a Malignancy Similarity Index (mSI™) to characterize incidental lung nodules, validated on over 1,500 patients.The tool has
Read More
Beyond Real-World Trial Iteration: QuantHealth Secures $45M for AI Clinical Simulation
What You Should Know
Tel Aviv-based AI clinical simulation platform QuantHealth closed a $45 million Series B financing round led by Qumra Capital.The round saw participation from major strategic and venture investors, including Sanofi Ventures, Pitango HealthTech, Bertelsmann Healthcare Investments (BHI), Artofin, GC Ventures, NewHealth, Shoni Top, and Esplanade Ventures.Proceeds will advance next-generation AI models, deepen scientific validation, expand therapeutic coverage beyond 40
Read More
H1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development
What You Should Know
Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader Novo Nordisk to modernize clinical trial development.Under the agreement, H1 will acquire rights to further advance StudyHub, Novo Nordisk's proprietary digital and AI-enabled platform for clinical trial execution.The collaboration combines H1's global Doctor Graph and AI-ready datasets with Novo Nordisk’s clinical trial operations to optimize protocol design, site
Read More
Epitel Closes $26M to Commercialize REMI Remote EEG Platform
What You Should Know
Salt Lake City-based digital health innovator Epitel, Inc. closed a $26M Series B funding round co-led by Catalyst Health Ventures and Genoa Ventures.The Series B financing supports the nationwide commercial footprint expansion of Epitel’s REMI® Remote EEG Monitoring System and REMI Vigilenz™ AI For Event Detection.Out of 9.2 million Americans experiencing seizures annually, 40% lack basic EEG access—largely because only 27% of U.S. hospitals possess native EEG diagnostic
Read More
Inocras Closes $31M for Whole-Genome Bioinformatics Platform
What You Should Know
San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M.The funding round was supported by strategic investors NDS Corporation and Aimed Bio Inc., alongside new investors IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, and Shinhan Securities.Proceeds will fund the U.S. expansion of
Read More
DeepHealth Receives FDA 510(k) Clearance for AI-Driven Breast Ultrasound Automation
What You Should Know
DeepHealth, Inc. (a wholly owned subsidiary of RadNet, Inc.) received FDA 510(k) clearance for DeepHealth Breast Ultrasound, an AI platform automating lesion detection, ACR BI-RADS characterization, and reporting.The commercial software allows U.S. healthcare providers to pursue reimbursement under an existing Category III CPT code for quantitative ultrasound tissue characterization.RadNet plans to deploy the platform across its national outpatient network by the end of
Read More
GE HealthCare Launches Invenia ABUS Prime for Dense Breast Screening
What You Should Know
GE HealthCare officially launched Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, extending its diagnostic ultrasound portfolio targeting dense breast tissue.ABUS StreamVue received U.S. FDA 510(k) clearance and CE Marking as a zero-footprint, browser-based reading platform developed in collaboration with Candelis, Inc. to enable remote multi-site exam review.Dense breasts affect approximately 40% of women across the U.S. and Europe, elevating
Read More
